Noubar Afeyan, Director, Ten Percent Owner at BG Medicine, holds 6.86M shares in Moderna (Ticker: MRNA), holds 17.14M shares in Seres Therapeutics (Ticker: MCRB), holds 1.29M shares in BG Medicine (Ticker: BGMD).
Noubar Afeyan latest transaction was an Uninformative Sell of $1.80M.
What was Noubar Afeyan's most profitable transaction?
Noubar Afeyan’s most profitable transaction was an Informative Sell of BGMD stock on December 11, 2015. The return on the trade was 91.90%.
What is Noubar Afeyan's role in BG Medicine?
Noubar Afeyan's role in BG Medicine is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.